Spyre Therapeutics, Inc.SYRENASDAQ
Loading
ROIC: Strong ReturnsExpanding
Percentile Rank92
Studio
Year-over-Year Change

Return on invested capital

Latest
-29.14%
↑ 58% vs avg
Percentile
P92
Near historical high
Streak
3 yr
Consecutive growthExpanding
Average
-70.21%
Historical baseline
PeriodValueYoY Change
2025-29.14%+22.5%
2024-37.62%+51.9%
2023-78.19%+47.2%
2022-148.20%-103.7%
2021-72.77%-29.9%
2020-56.00%+54.6%
2019-123.26%-83.0%
2018-67.35%-22.8%
2017-54.86%-58.0%
2016-34.72%-